No definition available.
Basal cell carcinoma, including avohilmo
C3_BASAL_CELL_CARCINOMA_INCLAVO_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpoints |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
Control exclude
C3_CANCER, C3_CANCER_WIDE
Extra metadata
Level in the ICD hierarchy
C
First used in FinnGen datafreeze
DF9
Similar endpoints
↥List of similar endpoints to
Basal cell carcinoma, including avohilmo
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 129419 | 68971 | 59907 |
| Only index persons | 120165 | 64764 | 55401 |
| Unadjusted period prevalence (%) | |||
| Whole population | 1.83 | 1.98 | 1.67 |
| Only index persons | 2.26 | 2.38 | 2.11 |
| Median age at first event (years) | |||
| Whole population | 74.14 | 74.60 | 73.60 |
| Only index persons | 73.78 | 74.19 | 73.31 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 23936 | 11555 | 12381 |
| Unadjusted period prevalence (%) | 5.41 | 4.54 | 6.22 |
| Median age at first event (years) | 68.40 | 67.00 | 69.71 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
Mortality – FinRegistry
↥Association
Association between endpoint C3_BASAL_CELL_CARCINOMA_INCLAVO_EXALLC and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| C3_BASAL_CELL_CARCINOMA_INCLAVO_EXALLC | 0.977 [0.89, 1.07] | 0.631 |
| Birth year | 0.995 [0.99, 1.0] | 0.189 |
During the follow-up period (1.1.1998 — 31.12.2019), 15622 out of 56089 females with C3_BASAL_CELL_CARCINOMA_INCLAVO_EXALLC died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| C3_BASAL_CELL_CARCINOMA_INCLAVO_EXALLC | 0.957 [0.86, 1.06] | 0.412 |
| Birth year | 0.987 [0.98, 1.0] | 0.004 |
During the follow-up period (1.1.1998 — 31.12.2019), 15173 out of 48341 males with C3_BASAL_CELL_CARCINOMA_INCLAVO_EXALLC died.
Mortality risk
Mortality risk for people of age
years, who have C3_BASAL_CELL_CARCINOMA_INCLAVO_EXALLC.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.073% | 0.156% |
| 5 | 0.473% | 0.995% |
| 10 | 1.282% | 2.585% |
| 15 | 2.678% | 5.036% |
| 20 | 4.546% | 8.682% |
Relationships between endpoints
↥Index endpoint: C3_BASAL_CELL_CARCINOMA_INCLAVO_EXALLC – Basal cell carcinoma, including avohilmo
GWS hits: 80
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data